Parkinson's disease Rehabilitation Centre - FERB ONLUS
Trescore Balneario, Italy
NCT Number: NCT04222218
Objective of the study:
To test the efficacy of theta burst cerebellar stimulation on postural instability in progressive supranuclear palsy using a cross-over design and wearing sensors technology
Design:
Twenty probable PSP patients with no dementia and still able to walk will be recruited for a cross-over sham-controlled study. Each patient will undergo a sham stimulation or a single session of cerebellar theta burst stimulation with a wash out period of at least 14 days.
Each patient will be evaluated before and after stimulation by berg balance tests (BBS), Tinetti scale, PSP-rating scale (PSP-RS), and a battery of gait and movement tests.
Static balance was assessed by 30-seconds-trials in semitandem and tandem positions with eyes open and closed using wearing sensors technology.
Looking for future studies?
Notify Me40 year–85 year
All sexes
Interventional
Not applicable
Trescore Balneario, Italy
Background:
There are no medical effective treatments for progressive supranuclear palsy (PSP). Imaging, neurophysiology and pathology studies suggested cerebellum as possible target of brain stimulation for postural instability using theta Burst repetitive Transcranial magnetic stimulation
Objective of the study:
To test the efficacy of theta burst cerebellar stimulation on postural instability in progressive supranuclear palsy using a cross-over design and wearing sensors technology
Design:
Probable PSP patients able to walk and without dementia/behavioral disturbances will be recruited for a cross-over sham-controlled study. Each patient will undergo a sham stimulation or a single session of cerebellar theta burst stimulation with a wash out period of at least 14 days.
Repetitive cerebellar theta burst stimulation will be performed by Duo-Mag XT100, using a 3 pulses at 50-Hz repeated at a rate of 5-Hz; 20 trains of 10 bursts given with 8-s intervals for a total of 600 pulses. Intensity of rTMS was set at the 80% of Amplitude of Motor Threshold (RMT) obtained in the left motor cortex for each subject.
A sample size of 20 subjects with complete stimulation (2 stimulations per subject, for a total number of stimulation)
Each patient will be evaluated before and after stimulation by berg balance tests (BBS), Tinetti scale, PSP-rating scale (PSP-RS), and a battery of gait and movement tests.
Static balance was assessed by 30-seconds-trials in semitandem and tandem positions with eyes open and closed using wearing sensors technology.
Sensors assessment:
The following parameters will be evaluated before and after stimulation (real vs sham): The parameter i) TIME, defined as time without falling ii) The parameter "surface", defined as the sway area iii) Velocity describes the mean velocity of the compensatory movements given in mm/s. iv) Acceleration described as root mean square (RMS), v) Jerk, the time derivate of acceleration, quantifies smoothness of the compensatory movements given in mG/s.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Cerebellar repetitive theta Burst stimulation will be performed as detailed in the Real arm description
Other names: rTMS, theta Burst, rTMS
Time frame: Changes from Baseline to immediately after stimulation
The short Physical performance battery included a walking test at convenient speed, a chair-rise test at convenient speed and tests of static balance including feet together, semi-tandem and tandem stance)
Time frame: Changes from Baseline to immediately after stimulation
The time of performance of two timed up and go test ( one starting with the right foot, one starting with the left foot) will be assessed
Time frame: Changes from Baseline to immediately after stimulation
The assessment of static balance will include four tasks, in which the patient has to stand alone and maintain the position in different conditions for up to 30 seconds: tandem and semitandem positions with eyes closed and eyes open, respectively.
The time of performance without falling will be assessed.
Time frame: Changes from Baseline to immediately after stimulation
Assessment of postural instability (0-28, higher scores indicate better performances)
Time frame: Changes from Baseline to immediately after stimulation
The area of sway during the postural instability tasks will be assessed (unit of measure mm2)
Time frame: Changes from Baseline to immediately after stimulation
Assessment of postural instability and disability of patients (scores ranging from 0 to 100, lower scores indicate less disability)
Time frame: Changes from Baseline to immediately after stimulation
the velocity of sway will be assessed during the postural instability tasks (unit of measure (mm/s)
Time frame: Changes from Baseline to immediately after stimulation
the acceleration of sway will be assessed during the postural instability tasks (unit of measure mm2/s)
Time frame: Changes from Baseline to immediately after stimulation
The time-derived of acceleration of sway will be assessed during the postural instability tasks (unit of measure mm3/s)
Fondazione Europea di Ricerca Biomedica Ferb Onlus
Other
Cerebellar rTMS Theta Burst for Postural Instability in Progressive Supranuclear Palsy: a Double Blind Cross-over Sham-controlled Study Using Wearing Sensors Technology
Acronym: CerTI-PSP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03924414
Atypical Parkinsonism, Autonomic Nervous System Diseases
Scottsdale, Arizona, United States
View Trial DetailsNCT04518059
Autonomic Nervous System Diseases, Basal Ganglia Diseases
Cleveland, Ohio, United States
View Trial DetailsNCT04237948
Basal Ganglia Diseases, Brain Diseases
Trescore Balneario, Italy
View Trial DetailsNCT02214862
Basal Ganglia Diseases, Brain Diseases
Barcelona, Spain
View Trial Details